Aspergillosis Treatment Market
According to Intent Market Research, the Aspergillosis Treatment Market is expected to grow from USD 3.0 Billion in 2024-e at a CAGR of 7.9% to touch USD 4.7 Billion by 2030. The Aspergillosis Treatment Market is dominated by key players such as Merck & Co., Inc., Astellas Pharma Inc., Novartis AG, GlaxoSmithKline plc, Amgen Inc., and Basilea Pharmaceutica Ltd.